2023 Annual Meeting | C70 - Trigeminal Neuralgia: Mimics, Pharmacotherapy, and Surgical/Interventional Treatment

Date Sunday 04/23/23

Time 03:30 PM - 05:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN

Topic(s) Headache

Learning Objectives Participants will be able to accurately diagnose trigeminal neuralgia based on International Classification of Headache Disorders 3; explain the pathophysiology and natural history of trigeminal neuralgia; select the optimal medication and interventional techniques used for the treatment of trigeminal neuralgia; and accurately diagnose conditions that at times mimic classical trigeminal neuralgia including trigeminal autonomic cephalgias, temporomandibular disorders, and distal branch neuralgias.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
03:30 PM - 04:05 PM EST	Speaker	Pathophysiology, Diagnosis, and Pharmacological Management of Trigeminal Neuralgia Fallon Schloemer, DO
04:05 PM - 04:40 PM EST	Speaker	Trigeminal Neuralgia Mimics: Headache and Orofacial Pain Differential Diagnosis and Management Marcela Romero-Reyes, DDS, PhD
04:40 PM - 05:15 PM EST	Speaker	Surgical/Interventional Management of Trigeminal Neuralgia Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN
05:15 PM - 05:30 PM EST	Discussion	Panel Discussion Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN, Fallon Schloemer, DO, Marcela Romero-Reyes, DDS, PhD

Faculty Disclosures
Paul G. Mathew, MD, DNBPAS, FAAN, FAHS, FAAN	Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie/Allergan. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Mathew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven/Pfizer. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Fallon Schloemer, DO	Dr. Schloemer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly . Dr. Schloemer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie .
Marcela Romero-Reyes, DDS, PhD	Marcela Romero-Reyes, DDS, PhD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Marcela Romero-Reyes, DDS, PhD has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pain Medicine OUP.

��ɫ��

��ɫ��